http://rdf.ncbi.nlm.nih.gov/pubchem/reference/28049172

Outgoing Links

Predicate Object
contentType Clinical Trial|Comparative Study|Journal Article|Randomized Controlled Trial|Research Support, Non-U.S. Gov't
endingPage 428
issn 0306-5251
1365-2125
issueIdentifier 5
pageRange 423-428
publicationName British Journal of Clinical Pharmacology
startingPage 423
bibliographicCitation De Visser SJ, Van Gerven JMA, Schoemaker RC, Cohen AF. Concentration‐effect relationships of two infusion rates of the imidazoline antihypertensive agent rilmenidine for blood pressure and development of side‐effects in healthy subjects. Brit J Clinical Pharma. 2001 May;51(5):423–8. doi: 10.1046/j.1365-2125.2001.01387.x.
creator http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_1b592c1124c5f90b33031980f7e804a0
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_415dbdea4670b4b5f88b3047796a9cc3
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_17b7b0d6da37d6a3f854b6165145e15b
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_2e305b25d094a9c77a698e8a434b2fe6
date 200105
identifier https://pubmed.ncbi.nlm.nih.gov/11421999
https://doi.org/10.1046/j.1365-2125.2001.01387.x
https://pubmed.ncbi.nlm.nih.gov/PMC2014466
isPartOf http://rdf.ncbi.nlm.nih.gov/pubchem/journal/1743
https://portal.issn.org/resource/ISSN/0306-5251
https://portal.issn.org/resource/ISSN/1365-2125
language English
source https://www.crossref.org/
https://pubmed.ncbi.nlm.nih.gov/
title Concentration‐effect relationships of two infusion rates of the imidazoline antihypertensive agent rilmenidine for blood pressure and development of side‐effects in healthy subjects
discusses http://id.nlm.nih.gov/mesh/M0001456
http://id.nlm.nih.gov/mesh/M0100916
http://id.nlm.nih.gov/mesh/M0015641
hasPrimarySubjectTerm http://id.nlm.nih.gov/mesh/D010080Q000494
http://id.nlm.nih.gov/mesh/D000959Q000494
http://id.nlm.nih.gov/mesh/D001794Q000187
hasSubjectTerm http://id.nlm.nih.gov/mesh/D010147Q000187
http://id.nlm.nih.gov/mesh/D004569Q000187
http://id.nlm.nih.gov/mesh/D012438Q000187
http://id.nlm.nih.gov/mesh/D004305
http://id.nlm.nih.gov/mesh/D010080Q000493
http://id.nlm.nih.gov/mesh/D004311
http://id.nlm.nih.gov/mesh/D006339Q000187
http://id.nlm.nih.gov/mesh/D010080Q000009
http://id.nlm.nih.gov/mesh/D008297
http://id.nlm.nih.gov/mesh/D000328
http://id.nlm.nih.gov/mesh/D000959Q000009
http://id.nlm.nih.gov/mesh/D000959Q000493
http://id.nlm.nih.gov/mesh/D012469Q000187
http://id.nlm.nih.gov/mesh/D018592
http://id.nlm.nih.gov/mesh/D012469Q000502
http://id.nlm.nih.gov/mesh/D006801
http://id.nlm.nih.gov/mesh/D000077769
http://id.nlm.nih.gov/mesh/D005260
http://id.nlm.nih.gov/mesh/D007262
discussesAsDerivedByTextMining http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID68156
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID68712

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128645717
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127664834

Total number of triples: 53.